Trends in Endocrinology & Metabolism
OpinionGenetic basis and variable phenotypic expression of Kallmann syndrome: towards a unifying theory
Section snippets
Idiopathic hypogonadotropic hypogonadism: clinical features and classification
Idiopathic hypogonadotropic hypogonadism (IHH) is defined by absent or delayed sexual development, with puberty being either absent or incomplete by the age of 18 years. This is associated with low or ‘inappropriately normal’ levels of the pituitary gonadotropin hormones luteinising hormone (LH) and follicle-stimulating hormone (FSH) [1]. In at least one genetic form of the disease, deficiency in human gonadotropin results from arrest in the migration of gonadotropin-releasing hormone (GnRH)
The physiological basis of IHH
Fundamental to understanding abnormalities of GnRH production or action is an understanding of the ontogeny and physiology of the GnRH neurons themselves. GnRH is secreted in discrete pulses into the hypophyseal portal circulation from nerve terminals at the median eminence by neurons having their cell bodies in the mediobasal hypothalamus. It stimulates pulsatile gonadotropin release from the anterior pituitary gland. GnRH neurons originate extracranially in the olfactory placode, and must
Overview of the genetic basis of IHH
Most unrelated cases of IHH are sporadic, with up to one-third showing some form of familial inheritance 1, 3. To date, mutations in one or more of a number of genes have been found in just over 50% of cases, with rare genetic variants encoding regulatory molecules within the FGFR1–FGF8 network (the FGF8 synexpression group, which appears to be crucial to olfactory-bulb ontogeny) accounting for the majority 36, 37; in the remainder, the underlying genetic susceptibility is not understood.
The
Hierarchical relationships among ligand–receptor systems determining GnRH secretion
The precise hierarchical relationships between the KISS1−KISS1R, GNRH1−GNRHR, tachykinin 3/tachykinin receptor 3 (TAC3−TACR3) systems in maintaining pulsatile GnRH secretion remain to be fully elucidated, but some of the underlying physiology is now known in some detail [47] (Figure 2). For instance, it is well established that exogenous pulsatile GnRH can normalise gonadotropin-mediated gonadal activity in the vast majority of patients with IHH, including some with GNRHR mutations [1], as well
Oligogenic inheritance in IHH
That inheritance of IHH was unlikely to be strictly mendelian was evident from the wide variations in reproductive and non-reproductive phenotypes exhibited by autosomal kindreds in historic studies [3]. This impression was reinforced with each new piece of the emerging IHH genetic puzzle. FGFR1 was originally thought to be a gene for autosomal KS [11], but detailed phenotyping of individuals carrying identical FGFR1 mutations later revealed a broad range of phenotypes, both within and between
Modulation of phenotype through genotype–environment interactions
Compound heterozygotes for a single IHH locus carry the same implications for the human gene pool as do the digenic/oligogenic cases. Their existence indicates that the population prevalence of mutated IHH alleles is sufficient to generate a stream of new autosomal recessive IHH cases even without consanguinity. Indeed, Sykiotis et al [27] found that 10% of their control group carried a single mutated allele, and this proportion will surely rise with the characterisation of novel IHH loci. That
Concluding remarks
Currently, about 65% of cases of IHH remain without a definite genetic cause and further genes undoubtedly remain to be discovered. Even those IHH cases with a single monoallelic variant are likely to harbour variants of undiscovered or unrecognised IHH-associated genes. Of the known genetic defects, most are unlikely to be causative per se in the heterozygous state, but can result in IHH when combined with other genetic susceptibilities, or can predispose to reversible HPG-axis suppression in
Acknowledgments
We would like to thank W Dhillo, London, UK for help with preparation of Figure 2.
References (107)
Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes
Mol. Cell. Endocrinol.
(2006)Spatiotemporal cell expression of luteinizing hormone–releasing hormone in the prenatal mouse: evidence for an embryonic origin in the olfactory placode
Brain Res. Dev. Brain. Res.
(1989)Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome
Brain Res. Mol. Brain Res.
(1989)WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome
Am. J. Hum. Genet.
(2010)Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome
Am. J. Hum. Genet.
(2008)- et al.
Effect of hypophysectomy on immunocytochemically demonstrated growth hormone releasing factor (GHRF) in the rat brain
Peptides
(1985) The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules
Cell
(1991)Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor
J. Biol. Chem.
(2002)Potential roles of the prokineticins in reproduction
Trends Endocrinol. Metab.
(2007)Novel mechanisms of fibroblast growth factor receptor 1 regulation by extracellular matrix protein anosmin-1
J. Biol. Chem.
(2009)
Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations
Endocr. Rev.
Impuberism and hypogonadism at induction into military service Statistical study
Probl. Actuels Endocrinol. Nutr.
Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization
Clin. Endocrinol. (Oxf.)
The genetic and clinical heterogeneity of gonadotropin-releasing hormone deficiency in the human
J. Clin. Endocrinol. Metab.
Isolated Gonadotropin-Releasing Hormone (GnRH)
Defic. Overview
A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules
Nature
X chromosome-linked Kallmann syndrome: stop mutations validate the candidate gene
Proc. Natl. Acad. Sci. U.S.A.
A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor
N. Engl. J. Med.
Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism
Nat. Genet.
Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome
Nat. Genet.
A novel homozygous splice acceptor site mutation of KISS1R in two siblings with normosmic isolated hypogonadotropic hypogonadism
Eur. J. Endocrinol.
Hypogonadotropic eunuchoidism I. Clinical study of the mode of inheritance
J. Clin. Endocrinol. Metab.
The syndrome of anosmia with hypogonadotropic hypogonadism: a genetic study of 18 new families and a review
Am. J. Med. Genet.
Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism
Proc. Natl. Acad. Sci. U.S.A.
Reversible kallmann syndrome, delayed puberty, and isolated anosmia occurring in a single family with a mutation in the fibroblast growth factor receptor 1 gene
J. Clin. Endocrinol. Metab.
Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia
J. Clin. Endocrinol. Metab.
A mutation in the fibroblast growth factor receptor 1 gene causes fully penetrant normosmic isolated hypogonadotropic hypogonadism
J. Clin. Endocrinol. Metab.
Nonsense mutations in FGF8 gene causing different degrees of human gonadotropin-releasing deficiency
J. Clin. Endocrinol. Metab.
Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype-phenotype correlations
Front. Horm. Res.
Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1
J. Androl.
Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum
J. Clin. Endocrinol. Metab.
Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2
PLoS Genet.
Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice
J. Clin. Invest.
Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism
J. Clin. Invest.
Oligogenic basis of isolated gonadotropin-releasing hormone deficiency
Proc. Natl. Acad. Sci. U.S.A.
A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes
J. Clin. Endocrinol. Metab.
Adult-onset idiopathic hypogonadotropic hypogonadism--a treatable form of male infertility
N. Engl. J. Med.
The long-term clinical follow-up and natural history of men with adult-onset idiopathic hypogonadotropic hypogonadism
J. Clin. Endocrinol. Metab.
Kallmann's syndrome: is it always for life?
Clin. Endocrinol. (Oxf.)
Reversal of idiopathic hypogonadotropic hypogonadism
N. Engl. J. Med.
A genetic basis for functional hypothalamic amenorrhea
NEJM
Mutations in the FGF8 genetic network underlie a large proportion of isolated human GnRH deficiency, in Endocrine
The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism
Nat. Rev. Endocrinol.
Isolated familial hypogonadotropic hypogonadism and a GNRH1 mutation
N. Engl. J. Med.
GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism
Proc. Natl. Acad. Sci. U.S.A.
Genetics of obesity in humans
Endocr. Rev.
Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene
Nat. Genet.
Brief report: impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function
N. Engl. J. Med.
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Nature
Cited by (130)
Spexin: Its role, regulation, and therapeutic potential in the hypothalamus
2022, Pharmacology and TherapeuticsCitation Excerpt :Reproductive function is controlled by the hypothalamic-pituitary-gonadal axis, with hypothalamic gonadotropin-releasing hormone (GnRH) expressing neurons at the apex of this system. GnRH is critical to reproductive function as disruption of GnRH neurons leads to hypogonadotropic hypogonadism and infertility (Mitchell, Dwyer, Pitteloud, & Quinton, 2011). GnRH secreted from these neurons acts on gonadotropes of the anterior pituitary, which in turn secrete luteinizing hormone (LH) and follicle-stimulating hormone (FSH).
Clinical and molecular features of idiopathic hypogonadotropic hypogonadism in Taiwan: A single center experience
2022, Journal of the Formosan Medical AssociationCases of Hypogonadotropic Hypogonadism: A Single-Center Experience
2023, Nigerian Journal of Clinical Practice